Client is difficult to arouse
🫁 This indicates opioid-induced CNS depression following morphine administration, raising concern for loss of airway protective reflexes and impending ventilatory compromise.
🫁 On the Pasero Opioid-Induced Sedation Scale (POSS), “difficult to arouse” corresponds to POSS 4 (somnolent)—a critical finding requiring immediate intervention (hold opioid, stimulate, and notify provider).
🫁 Excess sedation often precedes overt respiratory failure; early recognition is essential to prevent hypoventilation and hypoxemia.
🫁 Priority actions include arousal/stimulation, airway assessment, application of supplemental oxygen, and preparation for naloxone per protocol; increase monitoring frequency (prefer capnography if available).
🫁 Given timing (≈1 hr post-dose) and trend toward hemodynamic depression, vigilance for rapid deterioration is warranted.
Respirations 10/min
🫁 A rate <12/min signifies bradypnea and is a hallmark of opioid-induced respiratory depression due to suppressed medullary drive.
🫁 Reduced rate commonly coexists with shallow tidal volumes, causing hypercapnia and worsening oxygenation, even before saturation dramatically falls.
🫁 Immediate priorities: stimulate the patient, ensure airway patency, apply oxygen, and escalate to bag-valve-mask support if ventilation remains inadequate.
🫁 Hold additional opioids and notify the provider; be ready to administer naloxone with close post-reversal observation for renarcotization.
🫁 Initiate enhanced surveillance (continuous pulse oximetry and preferably end-tidal CO₂) to detect recurrent depression early.
Pulse oximetry 89% on room air
🫁 An SpO₂ of 89% reflects hypoxemia (target typically ≥94–95% in postoperative adults without chronic CO₂ retention), consistent with alveolar hypoventilation from opioid effect.
🫁 Hypoxemia in this context signals insufficient ventilation, not just an oxygenation problem; treating ventilation failure is as crucial as giving supplemental O₂.
🫁 Intervene with titrated oxygen (e.g., nasal cannula or face mask) while simultaneously addressing the underlying respiratory depression (stimulation, airway maneuvers, possible naloxone).
🫁 Assess for trend deterioration alongside the concurrent bradypnea and excess sedation, and escalate to higher levels of monitoring or RRT per facility policy.
🫁 Reassess frequently after interventions; document response and continue to withhold opioids until the patient is stable and alert.